December 21, 2024 - 14:34

As December approaches, the world’s richest individuals are once again making headlines with their extravagant holiday plans. This year, superyachts owned by billionaires such as Jeff Bezos and Barry Diller have been spotted in the picturesque Caribbean, where the warm climate and stunning vistas provide an idyllic backdrop for luxury vacations. These floating palaces are often equipped with all the amenities imaginable, catering to the lavish lifestyles of their owners.
However, not all ultrawealthy individuals are opting for sun-soaked beaches. A significant number are choosing to embrace the winter season, heading to snowy destinations like Aspen, Colorado, and St. Moritz, Switzerland. These locations offer not only world-class skiing but also exclusive resorts and high-end shopping experiences.
Whether basking in the sun or enjoying winter sports, the elite are ensuring their holiday experiences are nothing short of extraordinary, showcasing their penchant for luxury in every aspect of their lives.
January 25, 2026 - 20:36
Minnesota’s Biggest Companies Call for ‘De-escalation’ of TensionsChief executives from several of Minnesota`s largest and most prominent companies, including retail giant Target and agricultural conglomerate Cargill, have jointly issued a public letter calling...
January 25, 2026 - 12:28
Bob on Business: Fort Worth Stock Show with a high-end ‘Landman’ twistThe iconic Fort Worth Stock Show & Rodeo, a century-old celebration of Western heritage, is witnessing a notable shift in its patronage, reflecting the region`s booming energy sector. Observers...
January 24, 2026 - 23:38
How seat-back psychology helped a WA business build a safety card dynastyNestled in Lacey, Washington, a quiet manufacturing success story has been unfolding for decades, one airplane seat-back pocket at a time. A local company has become an unlikely dynasty, producing...
January 24, 2026 - 02:33
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trialsThe pharmaceutical company Moderna is scaling back its plans to invest in new late-stage clinical trials for infectious disease vaccines, citing a challenging environment. A significant factor in...